Grand River Hospital adopts Intellijoint HIP to study patient and health system benefits through $1 million provincial investment

The adoption of novel medical technologies in Canada, especially those not supported by available funding models, is extremely challenging. This provincial investment is the first of its kind and aims to create opportunities to support the adoption and explore funding for new and innovative technologies in health care.

The Ontario Ministry of Health recently announced, “to further support high-quality care in the region, the government is investing $1 million in a study at Grand River Hospital to evaluate the use of intraoperative surgical technology that could improve outcomes for patients who require hip replacement surgery. The study will inform the development of a new pathway to improve the adoption of new medical innovations that will innovate patient care in hospitals across the province.”

Intellijoint Surgical is proud that, as part of this announcement, Grand River Hospital will be adopting the use of Intellijoint’s intraoperative navigation solution for hip replacement, Intellijoint HIP, as part of a research study to understand the benefit of this new technology for patients, and identify any economic efficiencies that can be realized across the provincial health system as a result of its use.

Intellijoint HIP has been licensed by Health Canada since 2015 and provides real-time intraoperative measurements for accurate implant alignment, as well as leg length and offset restoration for total hip replacement surgery. Intellijoint HIP does not add any surgery time and has proven results with over 30,000 procedures performed around the world.

Previous
Previous

OBIO® Secures Funding to Support Health Science Innovators to Build Their Business Capacity in Ontario

Next
Next

Cosm Medical Raises $4.7 Million CAD for its Custom Gynecological Prosthetics